Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16537877 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease
Conditions: Diffuse Parenchymal Lung Disease;   Pulmonary Hypertension
Intervention: Drug: Oral sildenafil 20 mg

Indicates status has not been verified in more than two years